Skip to content

Magistra - Pharma

Active
Private limited companyfounded 1998active for 28 yearsMilcampslaan 3, 1030 Schaarbeek, BelgiumKBO/BCE: BE 0462.391.773
Summary

Magistra - Pharma has been active since 1998 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €187,834 and a net result of €35,189. Equity is growing by about 19% per year across the filed financial years. Its solvency ranks better than 74% of 22,479 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).

Overview

Activity
Retail sale of pharmaceutical products
NACE 47730
1 site
Size
€304,456total assets 2025
Staff
0.9 FTE
Equity
€187,834
Profit
€35,189
Turnover not published (abbreviated or micro format)
Financial health
97 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
0.1%
Structure
Parent
VANGOIDSENHOVEN INVEST · 100%
Accounts filed 2 days late2 of 3 deeds read
Why 97raises riskSector: Retail trade (NACE 47)lowers riskLiquidity: current ratio 2.53, cash €128,362Founded in 1998Equity €187,834 (61.7% of total assets)Show the evidence

Checked score

Score 2025
97 / 100
Excellent
Probability in this band: under 0.55%
Financially better than 78% of its sector peers (NACE 47, micro)
Financial strength · tick = 2024
Strong
Solvency 87+13
equity 61.7% of total assets
Liquidity 82+37
short-term debt 38.3% · cash 42.2%
Profitability 83+71
return on assets 11.6%
Bankruptcy probability, 12 months
0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.6% (40,213 companies, NACE 47, micro)
Last 24 months 11-2024: 0.8% 12-2024: 0.7%▼ -0.1 percentage points vs 11-2024 01-2025: 0.8%▲ +0.1 percentage points vs 12-2024 02-2025: 1.2%▲ +0.4 percentage points vs 01-2025highest value 03-2025: 0.4%▼ -0.8 percentage points vs 02-2025 04-2025: 0.4%● unchanged vs 03-2025 05-2025: 0.4%● unchanged vs 04-2025 06-2025: 0.4%● unchanged vs 05-2025 07-2025: 0.4%● unchanged vs 06-2025 08-2025: 0.4%● unchanged vs 07-2025 09-2025: 0.4%● unchanged vs 08-2025 10-2025: 0.4%● unchanged vs 09-2025 11-2025: 0.4%● unchanged vs 10-2025 12-2025: 0.4%● unchanged vs 11-2025 01-2026: 0.4%● unchanged vs 12-2025 02-2026: 0.7%▲ +0.3 percentage points vs 01-2026 03-2026: 0.1%▼ -0.6 percentage points vs 02-2026 04-2026: 0.1%● unchanged vs 03-2026 05-2026: 0.1%● unchanged vs 04-2026 06-2026: 0.1%● unchanged vs 05-2026 07-2026: 0.1%● unchanged vs 06-2026 08-2026: 0.1%● unchanged vs 07-2026 09-2026: 0.1%● unchanged vs 08-2026 10-2026: 0.1%● unchanged vs 09-2026lowest value
Credit of up to €18,000 on 30-day terms is acceptable
Liquidity ample (current ratio 2.53, compared with 1.83 in 2024, above the usual 1.5; short-term debt: 38.3% and cash: 42.2% of total assets), and 38.3% of the assets are financed with debt and provisions.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro): better than 74% on solvency, 86% on liquidity, 77% on profitability and 75% on growth.

The bankruptcy probability was computed on 21-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Five signals.
lowers riskraises riskneutral
lowers risk · Liquidity: current ratio 2.53, cash €128,362
NBB · annual accounts
lowers risk · Founded in 1998
Companies that have existed this long fail less often; how much that weighs depends on the rest of its profile.
KBO
lowers risk · Equity €187,834 (61.7% of total assets)
NBB · annual accounts
raises risk · Sector: Retail trade (NACE 47)
KBO
neutral · Filed after the deadline
The financial year that closed on 30-06-2025 was due by 31-01-2026 and was filed on 02-02-2026, 2 days later. Nearly half (47%) of Belgian companies file late; of those that file 1 to 90 days late, 2.0% are now bankrupt, dissolved or in another special legal status, against 1.66% of all filers. A delay like this does not count in the score.
NBB · 10 filings
Deviation from the deadline
2025
2 days late
2024
on the day
2023
271 days late
2022
on the day
2021
32 days early
2020
48 days early
2019
27 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 31 days after the deadline; the sector median (NACE 47) for financial year 2024 is on the deadline day, and 47% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The financial year that closed on 30-06-2026 is due by 31-01-2027. Nothing is late today. The company usually files around 31 January (4 of the last 5 filed years within 32 days of that day).
Companies Code · seven months
Where today falls in the filing period
30-06-2026 year end21-10-2026 today31-01-2027 deadline
neutral · No strike-offs in the KBO publications
Searched since 2021.
KBO publications · our coverage
  1. Annual accounts filedfinancial year 2025 · micro…
  2. Back to profitnet €35,189
  3. Annual accounts filedfinancial year 2024 · micro…

Key points

  • Positive: Back in profit in 2025after -€16,086 in 2024 €35,189 View
  • Positive: Among the best 17% on equitysector median €41,313 · 22,520 companies €187,834 View
  • Controlled by VANGOIDSENHOVEN INVEST 100% View

By topic

Financials

Financial year
2025
Total assets
€304,456
Profit
€35,189
Solvency
61.7%
Total assets▼ 2.5%
Net result
20192025
Go to Financials

Board & ownership

Board
2 members
Parent
VANGOIDSENHOVEN INVEST · 100%
  • AMALOU AhseneDirector
  • ZAKMOUT OussamaDirector
Go to Board & ownership

Timeline

Events
34
Since
2000
Next accounts
by 31-01-2027
  1. 28-10-2024Annual accounts filed
  2. 21-08-2024Reappointments: ZAKMOUT Oussama (director) and AMALOU Ahsene…
  3. 09-08-2024Amendment of the articles
Go to Timeline

Company details

Sites
1
Legal form
Private limited company
Activity
Retail sale of pharmaceutical productsNACE 47730
Founded
15-01-1998
Year ends
30-06
Peppol
Reachable for e-invoices
Go to Company details

Articles of association

Provisions read
12
Annual meeting
First Wednesday of December at 12:00
Purpose
“L'exercice de toutes les activités qui relèvent normalement de l'équilibre d'une pharmacie…” (deed in French)
Go to Articles of association

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.